6. MOUNJARO 7.5 MG BENEFITS - AN OVERVIEW

Individuals with T2D are twice as more likely to have cardiovascular disease or stroke when compared to a person without having diabetes, and at a young age, per the agency.In Grownup individuals with type two diabetes mellitus, therapy with MOUNJARO generated a statistically important reduction from baseline in HbA1c when compared with placebo.All